Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
17%

OVERLAP
BY WEIGHT
14

# OF OVERLAPPING
HOLDINGS
XPH
57
HOLDINGS
24%
ALSO IN SBIO
SBIO
84
HOLDINGS
17%
ALSO IN XPH
SECTOR DRIFT (XPH minus SBIO)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XPH
Weight
in SBIO
Overlap
VERADERMICS INC 2.8% 3.9% 2.8%
DEFINIUM THERAPEUTICS INC 1.9% 3.2% 1.9%
TARSUS PHARMACEUTICALS, INC. 1.8% 2.2% 1.8%
EDGEWISE THERAPEUTICS, INC. 1.8% 2.8% 1.8%
AMYLYX PHARMACEUTICALS, INC. 1.8% 2.4% 1.8%
XPH Overweight Relative to SBIO
PACIRA PHARMACEUTICALS INC 2.5%
ELI LILLY & CO 2.5%
AMNEAL PHARMACEUTICALS, INC. CLASS A 2.5%
VIATRIS, INC. 2.3%
LIGAND PHARMACEUTICALS-CL B 2.2%
ROYALTY PHARMA PLC CLASS A 2.2%
PERRIGO CO 2.2%
PFIZER INC 2.2%
ZOETIS INC 2.2%
SEPTERNA INC 2.2%
XPH Underweight Relative to SBIO
ORUKA THERAPEUTICS INC -4.3%
CG ONCOLOGY, INC. -3.8%
TRAVERE THERAPEUTICS, INC. -3.2%
DIANTHUS THERAPEUTICS INC -3.1%
RELAY THERAPEUTICS, INC. -2.7%
ACADIA PHARMACEUTICALS INC -2.4%
DYNE THERAPEUTICS INC -2.1%
DISC MEDICINE, INC. -2.1%
IDEAYA BIOSCIENCES, INC. -2.1%
DENALI THERAPEUTICS INC. -2.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY